BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Fluoxetine
,
rs3825942
,
PBX1
,
T cell differentiation
,
Diabetes mellitus
,
Kidney
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
solifenacin
Summary
General Info
Curated Studies
Most Correlated Studies
Drug target sets for approved compounds
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Explore Curated Studies Results
Literature
Most Relevant Literature
Expeditive Chromatographic Methods for Quantification of Solifenacin Succinate along with its Offici…
Micellar-enhanced and green-assessed first-derivative synchronous spectrofluorimetric approach for c…
Solifenacin promotes remyelination in cuprizone mouse model by inhibiting the Wnt/β-catenin signalin…
State-of-the-art mathematically induced filtration approaches for smart spectrophotometric assessmen…
Efficacy and safety of solifenacin combined with biofeedback in children with overactive bladder.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Feasibility of "At-home" Titration of Solifenacin
Evaluation of Adherence to Solifenacin Treatment in Overactive Bladder Patients
Comparison of Tamsulosin and Solifenacin in Treatment of Ureteral Stent Symptoms
Electroacupuncture and Solifenacin for Urgency-predominant Mixed Urinary Incontinence
Efficacy and Safety of the Mirabegron Compared With Solifenacin in Treatment of Overactive Bladder
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ